Hematology and Oncology
Impact of Cancer-Related Decision Aids
July 2002
Clinical Focus*
- What models of decisionmaking (e.g., informed, shared) underpin decision aids that have been used?
- What clinical contexts (e.g., prevention, screening, and treatment) have been investigated?
- What has been the clinical focus of the decision aids (e.g., type of cancer and extent of disease)?
- What has been the mode of delivery (e.g., print, interactive video)?
- On what populations has the research been conducted?
- Have decision aids been developed for or used by members of special populations (e.g., elderly, ethnic groups, and low level of education)?
- What outcomes have been evaluated (e.g., increase in knowledge, satisfaction, and behaviors)?
- Are there any key outcomes that are associated with specific characteristics of decision aids?
- What is the effectiveness of decision aids?
- What is the effectiveness of decision aids in different clinical contexts?
- What is the effectiveness of different modes of delivery?
- What is the effectiveness of decision aids on special populations?
- What specific direction is needed in future research on cancer-related decision aids?
*Addressed in the summary or evidence report.
Impact of Cancer-Related Decision Aids
Summary (Publication No. 02-E033, July 2002)
Evidence Report (Publication No. 02-E004, July 2002)
(File Download)
EPC: McMaster University
Topic Nominator: National Cancer Institute
Return to Quick Menu: Evidence Report Topics
Return to Evidence-based Practice